Mylan, Teva Lose Bid to Scale Back Generic Drug Antitrust Case

Read the Bloomberg Law article.

Previous
Previous

Member Spotlight: Roberta “Bobbi” Liebenberg

Next
Next

Wawa Gets Nod for $12M Consumer Data Breach Settlement